Allscripts Healthcare Solutions (MDRX) Upgraded to Buy at BidaskClub

Allscripts Healthcare Solutions (NASDAQ:MDRX) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday, December 20th.

Several other equities research analysts have also weighed in on the company. KeyCorp restated a “hold” rating on shares of Allscripts Healthcare Solutions in a research report on Friday, October 27th. Zacks Investment Research downgraded Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a report on Wednesday, November 8th. Robert W. Baird boosted their target price on Allscripts Healthcare Solutions from $16.00 to $17.00 and gave the stock an “outperform” rating in a report on Friday, November 3rd. Cowen raised Allscripts Healthcare Solutions from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $13.00 to $16.00 in a report on Monday, September 11th. Finally, SunTrust Banks reissued a “buy” rating and issued a $16.00 target price on shares of Allscripts Healthcare Solutions in a report on Friday, November 3rd. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and twelve have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $15.53.

Allscripts Healthcare Solutions (MDRX) traded up $0.09 during midday trading on Wednesday, hitting $16.03. The company had a trading volume of 1,440,000 shares, compared to its average volume of 2,320,000. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 1.20. Allscripts Healthcare Solutions has a one year low of $11.01 and a one year high of $16.12. The company has a market capitalization of $2,900.00, a price-to-earnings ratio of -13.82, a PEG ratio of 2.17 and a beta of 1.32.

In other news, President Richard J. Poulton sold 15,000 shares of the business’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $14.26, for a total value of $213,900.00. Following the completion of the transaction, the president now owns 1,351,773 shares in the company, valued at $19,276,282.98. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Brian Farley sold 5,000 shares of the business’s stock in a transaction on Thursday, December 14th. The stock was sold at an average price of $14.35, for a total value of $71,750.00. Following the completion of the transaction, the executive vice president now owns 191,607 shares of the company’s stock, valued at approximately $2,749,560.45. The disclosure for this sale can be found here. Insiders sold 56,796 shares of company stock valued at $804,842 in the last 90 days. Company insiders own 0.91% of the company’s stock.

Several hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. raised its stake in shares of Allscripts Healthcare Solutions by 1.2% in the second quarter. Vanguard Group Inc. now owns 14,824,640 shares of the software maker’s stock worth $189,162,000 after purchasing an additional 181,721 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Allscripts Healthcare Solutions by 3.7% in the third quarter. Dimensional Fund Advisors LP now owns 9,508,667 shares of the software maker’s stock worth $135,308,000 after purchasing an additional 337,382 shares during the last quarter. Fiduciary Management Inc. WI raised its stake in shares of Allscripts Healthcare Solutions by 0.6% in the second quarter. Fiduciary Management Inc. WI now owns 6,083,536 shares of the software maker’s stock worth $77,626,000 after purchasing an additional 38,426 shares during the last quarter. State Street Corp raised its stake in shares of Allscripts Healthcare Solutions by 28.6% in the second quarter. State Street Corp now owns 5,975,551 shares of the software maker’s stock worth $76,251,000 after purchasing an additional 1,330,721 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. raised its stake in shares of Allscripts Healthcare Solutions by 1.0% in the third quarter. Fuller & Thaler Asset Management Inc. now owns 5,062,035 shares of the software maker’s stock worth $72,033,000 after purchasing an additional 49,823 shares during the last quarter.

ILLEGAL ACTIVITY WARNING: “Allscripts Healthcare Solutions (MDRX) Upgraded to Buy at BidaskClub” was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this piece on another website, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The correct version of this piece can be accessed at https://ledgergazette.com/2018/01/13/allscripts-healthcare-solutions-mdrx-upgraded-to-buy-at-bidaskclub.html.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply